Neolara CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
NeoLara Corp. reports for the quarter ended March 31, 2026, highlighting its continued maintenance stage with no operating revenue and significant net loss, while managing reporting obligations.
OTC.Pink
Neolara Corp. reports no revenue for Q2 2026, with a net loss of $8,772, and significant impairment charges impacting its financial position.
OTC.Pink
Neolara Corp. reports zero revenue and a net loss of $73,621 for the quarter ended September 30, 2025, amid ongoing going-concern challenges.
OTC.Pink
Development-stage construction firm Neolara Corp. disclosed increased net losses and significantly reduced cash reserves for the quarter ended March 31, 2025, alongside substantial doubt about its ability to continue as a going concern.
OTC.Pink
Neolara Corp's Q2 2025 results reveal a decrease in revenue and an increase in net loss compared to the same period last year, alongside concerns about the company's ability to continue as a going concern.
OTC.Pink
Neolara Corp's Q1 2024 financial results reveal a decrease in revenue and a net loss compared to the same period last year, as the company focuses on negotiations with potential customers.
OTC.Pink
Neolara Corp.'s Q3 2024 results show mixed performance with revenue fluctuations and continued losses as the company focuses on development and faces going concern challenges.